A new study adds to a growing body of evidence that semaglutide has benefits other than weight loss or controlling diabetes.

Advertising regulator launches nine investigations into weight loss jab ads - Exclusive: ASA calls number of parallel probes ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Semaglutide, a medication widely used for diabetes and weight loss, may offer another unexpected benefit -- it could help ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...

In 2022, when the surge in popularity of the GLP-1 class of weight loss and diabetes drugs really began, stories of surprise ...

The drug semaglutide has been linked to a lower risk of alcoholism before, but now we have strong evidence that it really ...

Yet another study is supporting the notion that the blockbuster GLP-1 drug Ozempic can help problems drinkers curb their ...

It also touts the non-FDA-approved Hims & Hers weight-loss drug as the supreme and affordable solution to America’s obesity ...

Elkhorn Logan Valley Public Health Department’s Scale Down program will begin next month in Norfolk. This program is designed ...

The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...